Dr. Jayanth Koneru, M.D.
What this data tells you about Dr. Koneru
Dr. Jayanth Koneru is an interventional cardiology in Ocala, FL, with 16 years in practice. Based on federal Medicare data, Dr. Koneru performed 6,821 Medicare services across 4,011 unique beneficiaries.
Between the years covered by Open Payments, Dr. Koneru received a total of $24,578 from 30 pharmaceutical and/or device companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Koneru is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,465 | $89 | $235 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,320 | $45 | $108 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 638 | $315 | $800 |
| Electrocardiogram (EKG), 12-lead | 371 | $10 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 331 | $54 | $142 |
| Hospital follow-up visit, moderate complexity | 327 | $63 | $149 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 319 | $2,045 | $4,717 |
| Nuclear medicine study of heart muscle blood flow by pet | 317 | $139 | $342 |
| Initial hospital admission, moderate complexity | 314 | $104 | $276 |
| Echocardiogram, transthoracic | 256 | $140 | $397 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 250 | $27 | $71 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 206 | $20 | $54 |
| New patient office visit, complex (60-74 min) | 104 | $160 | $428 |
| Remote pacemaker/defibrillator monitoring, 90 days | 99 | $14 | $49 |
| Hospital follow-up visit, low complexity | 93 | $40 | $81 |
| Remote pacemaker monitoring, 90 days | 69 | $20 | $61 |
| Programming of dual lead pacemaker system | 58 | $56 | $138 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 39 | $20 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $11 | $30 |
| Ultrasound of both sides of head and neck blood flow | 33 | $140 | $387 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $138 | $394 |
| Initial hospital admission, high complexity | 24 | $138 | $369 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 24 | $170 | $215 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $627 | $1,480 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 21 | $67 | $201 |
| New patient office visit (45-59 min) | 16 | $114 | $332 |
| Office visit, established patient (10-19 min) | 16 | $28 | $94 |
| Office visit, established patient (20-29 min) | 15 | $53 | $173 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 13 | $294 | $870 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Koneru is a cardiac imaging specialist, with above-average Medicare volume (top 15% in FL), and speaking/promotional industry engagement, with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Koneru experienced with office visit, established patient (30-39 min)?
Does Dr. Koneru receive payments from pharmaceutical companies?
How do Dr. Koneru's costs compare to other interventional cardiologys in Ocala?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology